María Javier
Ramírez Gil
Catedrática de Universidad
Karolinska Institute
Estocolmo, SueciaPublicaciones en colaboración con investigadores/as de Karolinska Institute (9)
2023
-
SIRT2 Inhibition Rescues Neurodegenerative Pathology but Increases Systemic Inflammation in a Transgenic Mouse Model of Alzheimer’s Disease
Journal of Neuroimmune Pharmacology, Vol. 18, Núm. 3, pp. 529-550
2018
-
Increased Levels of Brain Adrenomedullin in the Neuropathology of Alzheimer’s Disease
Molecular Neurobiology, Vol. 55, Núm. 6, pp. 5177-5183
2017
-
GPR55: A therapeutic target for Parkinson's disease?
Neuropharmacology, Vol. 125, pp. 319-332
-
Modulation of BDNF cleavage by plasminogen-activator inhibitor-1 contributes to Alzheimer's neuropathology and cognitive deficits
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1863, Núm. 4, pp. 991-1001
2015
-
Alterations in brain leptin signalling in spite of unchanged CSF leptin levels in Alzheimer's disease
Aging Cell, Vol. 14, Núm. 1, pp. 122-129
-
Decreased levels of guanosine 3', 5'-monophosphate (cGMP) in cerebrospinal fluid (CSF) are associated with cognitive decline and amyloid pathology in Alzheimer's disease
Neuropathology and Applied Neurobiology, Vol. 41, Núm. 4, pp. 471-482
2011
-
Cholinergic hypofunction impairs memory acquisition possibly through hippocampal Arc and BDNF down regulation
Hippocampus, Vol. 21, Núm. 9, pp. 999-1009
2010
-
HPA axis dysregulation associated to apolipoprotein E4 genotype in Alzheimer's disease
Journal of Alzheimer's Disease, Vol. 22, Núm. 3, pp. 829-838
-
Insulin levels are decreased in the cerebrospinal fluid of women with prodomal alzheimer's disease
Journal of Alzheimer's Disease, Vol. 22, Núm. 2, pp. 405-413